Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31401 - 31425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	AKAP2	11217	downregulated	Cisplatin results in decreased expression of AKAP2 mRNA	9q31.3	A22204
Cisplatin	Approved Investigational	AKR1B10	57016	upregulated	Cisplatin results in increased expression of AKR1B10 mRNA	7q33	A22204
Cisplatin	Approved Investigational	AKR1C1	1645	upregulated	Cisplatin results in increased expression of AKR1C1 mRNA	10p15.1	A22208
Cisplatin	Approved Investigational	AKR1C2	1646	downregulated	Cisplatin results in decreased expression of AKR1C2 mRNA	10p15.1	A20662
Cisplatin	Approved Investigational	AKR1C2	1646	upregulated	Cisplatin results in increased expression of AKR1C2 mRNA	10p15.1	A20427
Cisplatin	Approved Investigational	AKR1C3	8644	upregulated	Cisplatin results in increased expression of AKR1C3 mRNA	10p15.1	A22208
Cisplatin	Approved Investigational	AKT1	207	downregulated	Cisplatin results in decreased expression of AKT1 mRNA	14q32.33	A22209
Cisplatin	Approved Investigational	ALDH18A1	5832	downregulated	Cisplatin results in decreased expression of ALDH18A1 mRNA	10q24.1	A22203 A20427
Cisplatin	Approved Investigational	ALDH1A1	216	downregulated	Cisplatin results in decreased expression of ALDH1A1 mRNA	9q21.13	A22210
Cisplatin	Approved Investigational	ALDH1A3	220	upregulated	Cisplatin results in increased expression of ALDH1A3 mRNA	15q26.3	A20427
Cisplatin	Approved Investigational	ALDOA	226	upregulated	Cisplatin results in increased expression of ALDOA mRNA	16p11.2	A20427
Cisplatin	Approved Investigational	ALDOC	230	downregulated	Cisplatin results in decreased expression of ALDOC mRNA	17q11.2	A22203
Cisplatin	Approved Investigational	ALG2	85365	upregulated	Cisplatin results in increased expression of ALG2 mRNA	9q22.33	A22204
Cisplatin	Approved Investigational	ANG	283	upregulated	Cisplatin results in increased expression of ANG mRNA	14q11.2	A22204
Cisplatin	Approved Investigational	ANGPTL4	51129	upregulated	Cisplatin results in increased expression of ANGPTL4 mRNA	19p13.2	A20427
Cisplatin	Approved Investigational	ANKRA2	57763	downregulated	Cisplatin results in decreased expression of ANKRA2 mRNA	5q13.2	A20427
Cisplatin	Approved Investigational	ANKRD11	29123	downregulated	Cisplatin results in decreased expression of ANKRD11 mRNA	16q24.3	A22204
Cisplatin	Approved Investigational	APOC3	345	downregulated	Cisplatin results in decreased expression of APOC3 mRNA	11q23.3	A22210
Cisplatin	Approved Investigational	ARHGAP10	79658	upregulated	Cisplatin results in increased expression of ARHGAP10 mRNA	4q31.23	A22204
Cisplatin	Approved Investigational	ARHGAP22	58504	downregulated	Cisplatin results in decreased expression of ARHGAP22 mRNA	10q11.22-q11.23	A22204
Cisplatin	Approved Investigational	ARHGAP24	83478	downregulated	Cisplatin results in decreased expression of ARHGAP24 mRNA	4q21.23-q21.3	A22211
Cisplatin	Approved Investigational	ARHGEF10	9639	downregulated	Cisplatin results in decreased expression of ARHGEF10 mRNA	8p23.3	A20427
Cisplatin	Approved Investigational	ARHGEF26	26084	upregulated	Cisplatin results in increased expression of ARHGEF26 mRNA	3q25.2	A20660
Cisplatin	Approved Investigational	ARPC1A	10552	upregulated	Cisplatin results in increased expression of ARPC1A mRNA	7q22.1	A22205
Cisplatin	Approved Investigational	ARPC1B	10095	upregulated	Cisplatin results in increased expression of ARPC1B mRNA	7q22.1	A22205

Displaying entries 31401 - 31425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability